Refresh

Piramal Pharma Ltd. - Research Center

543635 PPLPHARMA Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income

Operating income

4,390.11 3,443.22 3,094.95 2,938.81
Expenses

Material consumed

2,194.78 1,851.29 1,537.18 1,275.27

Manufacturing expenses

112.89 107.94 68.97 68.08

Personnel expenses

613.93 548.50 425.30 395.15

Selling expenses

107.33 138.71 122.94 85.53

Adminstrative expenses

743.26 699.25 543.26 495.85

Expenses capitalised

- - - -

Cost of sales

3,772.19 3,345.69 2,697.65 2,319.88

Operating profit

617.92 97.53 397.30 618.93

Other recurring income

202.06 341.07 223.59 197.97

Adjusted PBDIT

819.98 438.60 620.89 816.90

Financial expenses

107.10 115.87 53.55 4.71

Depreciation

205.26 192.08 130.64 143.64

Other write offs

- - - -

Adjusted PBT

507.62 130.65 436.70 668.55

Tax charges

116.40 54.19 81.18 115.28

Adjusted PAT

391.22 76.46 355.52 553.27

Non recurring items

-3.78 -9.53 -12.18 15.77

Other non cash adjustments

- - - -

Reported net profit

387.44 66.93 343.34 569.04

Earnigs before appropriation

1,359.23 985.19 912.38 569.04

Equity dividend

- - - -

Preference dividend

- - - -

Dividend tax

- - - -

Retained earnings

1,359.23 985.19 912.38 569.04
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com